Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “The Board of Regents of the University of Texas System”

1,742 pharma patents match "The Board of Regents of the University of Texas System" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 1,742
Index total 30,257
Page 39 / 73

Quick answer

This filtered view shows 1,742 pharmaceutical patents matching "The Board of Regents of the University of Texas System" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

1,742 results for “The Board of Regents of the University of Texas System” · 30,257 patents in full index Clear search

  1. US 9278923

    Pro-neurogenic compounds

    The Board of Regents of the University of Texas System · Granted Mar 8, 2016 · Expires Mar 3, 2036

    granted
  2. US 9278068

    Vesicle compositions

    The Board of Regents of the University of Texas System · Granted Mar 8, 2016 · Expires Mar 3, 2036

    granted
  3. US 9278113

    Titanium dioxide nanotubes for production and delivery of nitric oxide and methods for production thereof

    The Board of Regents of the University of Texas System · Granted Mar 8, 2016 · Expires Mar 3, 2036

    granted
  4. US 9272991

    Eicosanoid derivatives

    The Board of Regents of the University of Texas System · Granted Mar 1, 2016 · Expires Feb 25, 2036

    granted
  5. US 9273288

    Pseudoinfectious flavivirus and uses thereof

    The Board of Regents of the University of Texas System · Granted Mar 1, 2016 · Expires Feb 25, 2036

    granted
  6. US 9267947

    Compositions and methods for preventing or treating Burkholderia infection

    The Board of Regents of the University of Texas System · Granted Feb 23, 2016 · Expires Feb 18, 2036

    granted
  7. US 9265844

    Protease degradable polypeptides and uses thereof

    The Board of Regents of the University of Texas System · Granted Feb 23, 2016 · Expires Feb 18, 2036

    granted
  8. US 9260510

    Pertussis antibodies and uses thereof

    The Board of Regents of the University of Texas System · Granted Feb 16, 2016 · Expires Feb 11, 2036

    granted
  9. US 9250239

    Compositions and methods for detecting microbial infections

    The Board of Regents of the University of Texas System · Granted Feb 2, 2016 · Expires Jan 28, 2036

    granted
  10. US 9248147

    Methods for endoscopic mucosal resection and endoscopic submucosal dissection

    The Board of Regents of the University of Texas System · Granted Feb 2, 2016 · Expires Jan 28, 2036

    granted
  11. US 9243055

    HERV-K antigens, antibodies, and methods

    The Board of Regents of the University of Texas System · Granted Jan 26, 2016 · Expires Jan 21, 2036

    granted
  12. US 9241999

    Method of producing physiological and therapeutic levels of nitric oxide through an oral delivery system

    The Board of Regents of the University of Texas System · Granted Jan 26, 2016 · Expires Jan 21, 2036

    granted
  13. US 9241998

    Methods and compositions for treatment of cancer using oncolytic RSV activity

    The Board of Regents of the University of Texas System · Granted Jan 26, 2016 · Expires Jan 21, 2036

    granted
  14. US 9243351

    Fabrication of biscrolled fiber using carbon nanotube sheet

    The Board of Regents of the University of Texas System · Granted Jan 26, 2016 · Expires Jan 21, 2036

    granted
  15. US 9243281

    Neuroprotective chemicals and methods for identifying and using same

    The Board of Regents of the University of Texas System · Granted Jan 26, 2016 · Expires Jan 21, 2036

    granted
  16. US 9238653

    Antimalarial agents that are inhibitors of dihydroorotate dehydrogenase

    The Board of Regents of the University of Texas System · Granted Jan 19, 2016 · Expires Jan 14, 2036

    granted
  17. US 9233162

    High affinity VEGF-receptor antagonists

    The Board of Regents of the University of Texas System · Granted Jan 12, 2016 · Expires Jan 7, 2036

    granted
  18. US 9221800

    Isoxazole treatments for diabetes

    The Board of Regents of the University of Texas System · Granted Dec 29, 2015 · Expires Dec 24, 2035

    granted
  19. US 9216220

    Compositions and methods for thermo-sensitive nanoparticles and magnetic nanoparticles

    The Board of Regents of the University of Texas System · Granted Dec 22, 2015 · Expires Dec 17, 2035

    granted
  20. US 9216198

    Compositions and medical devices for controlled release of nitric oxide and methods of production thereof

    The Board of Regents of the University of Texas System · Granted Dec 22, 2015 · Expires Dec 17, 2035

    granted
  21. US 9216983

    Dihydroorotate dehydrogenase inhibitors with selective anti-malarial activity

    The Board of Regents of the University of Texas System · Granted Dec 22, 2015 · Expires Dec 17, 2035

    granted
  22. US 9212218

    Vmp-like sequences of pathogenic Borrelia

    The Board of Regents of the University of Texas System · Granted Dec 15, 2015 · Expires Dec 10, 2035

    granted
  23. US 9211419

    Treatments of disease or disorders using nanoparticles for focused hyperthermia to increase therapy efficacy

    The Board of Regents of the University of Texas System · Granted Dec 15, 2015 · Expires Dec 10, 2035

    granted
  24. US 9200015

    Inositol hexakisphosphate analogs and uses thereof

    The Board of Regents of the University of Texas System · Granted Dec 1, 2015 · Expires Nov 26, 2035

    granted